{"gene":"CRLS1","run_date":"2026-06-09T22:57:19","timeline":{"discoveries":[{"year":1998,"finding":"CLS1 (yeast ortholog of CRLS1) encodes cardiolipin synthase, which catalyzes the final step in cardiolipin synthesis from phosphatidylglycerol and CDP-diacylglycerol, localized predominantly to the mitochondrial inner membrane. Disruption of CLS1 abolished cardiolipin synthase activity, eliminated detectable cardiolipin, and elevated phosphatidylglycerol levels ~5-fold.","method":"Gene disruption/knockout, overexpression in yeast and baculovirus-infected insect cells with enzymatic activity assays, lipid analysis, and mitochondrial dye staining","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct enzymatic activity assay in multiple expression systems, null mutant with definitive biochemical phenotype, replicated in yeast and insect cells","pmids":["9614098"],"is_preprint":false},{"year":2009,"finding":"Human CRLS1 (hCLS1) possesses a second enzymatic activity: an acyl-CoA-dependent lysophosphatidylglycerol (LPG) acyltransferase that remodels PG by acylating LPG to PG, in addition to its cardiolipin synthase activity. Purified recombinant hCLS1 displayed acyl selectivity (C18:1 > C18:2 > C18:0 > C16:0) for both activities. No significant acyltransferase activity was detected toward lysocardiolipin. Overexpression in COS-7 cells increased both PG biosynthesis and cardiolipin levels without affecting other phospholipids.","method":"Recombinant protein expression in COS-7 and Sf-9 insect cells, purified protein in vitro acyltransferase assays, lipid mass spectrometry/radiolabeling, overexpression with lipid profiling","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro enzymatic assay with purified protein, multiple expression systems, acyl selectivity profiling, and cell overexpression functional validation in a single study","pmids":["20025994"],"is_preprint":false},{"year":2022,"finding":"Biallelic loss-of-function variants in human CRLS1 cause cardiolipin deficiency: patient-derived fibroblasts showed reduced cardiolipin levels, altered acyl-chain composition, and significantly elevated phosphatidylglycerol (the CRLS1 substrate), alongside impaired mitochondrial morphology and biogenesis. Mouse Crls1 knockout cell lines revealed endoplasmic reticular and mitochondrial stress responses upon cardiolipin insufficiency.","method":"Patient-derived fibroblast lipid profiling (lipidomics), proteomic profiling, mouse Crls1 knockout cell lines, mitochondrial morphology assays (microscopy)","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (lipidomics, proteomics, KO cell lines, morphology imaging) across patient and mouse model systems in a single study","pmids":["35147173"],"is_preprint":false},{"year":2024,"finding":"Crls1 knockdown in myoblasts reduced mitochondrial mass, oxidative phosphorylation complex IV expression, and disrupted mitochondrial cristae structure. In vivo, AAV9-shCrls1-mediated Crls1 knockdown impaired muscle regeneration after cardiotoxin injury in mice, whereas AAV9-mCrls1 overexpression improved regeneration, establishing that Crls1 is required for maintaining mitochondrial quality in skeletal muscle myogenesis.","method":"shRNA knockdown and AAV9-mediated overexpression/knockdown in mouse model, mitochondrial activity assays, electron microscopy of cristae, in vivo muscle regeneration model","journal":"Experimental & molecular medicine","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo loss- and gain-of-function with defined phenotypic readouts (mitochondrial morphology, OXPHOS complex expression, muscle regeneration) in a single study with multiple orthogonal methods","pmids":["38556544"],"is_preprint":false},{"year":2025,"finding":"CRLS1 functions downstream in the cardiolipin synthesis pathway at mitochondria; depletion of CRLS1 (along with PTPMT1 or PRELID1) prevents apoptosis caused by BLTP1 deficiency, indicating that CRLS1-mediated cardiolipin synthesis contributes to pathological lipid overload-driven apoptosis when mitochondrial phospholipid efflux is blocked.","method":"Genetic epistasis: CRLS1 depletion in BLTP1-deficient cells with apoptosis readout; lipid profiling showing PG and CL accumulation","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — genetic epistasis with defined apoptosis readout, single preprint lab study, pathway placement supported by lipid accumulation data but not yet peer-reviewed","pmids":["bio_10.1101_2025.09.30.679455"],"is_preprint":true},{"year":2026,"finding":"Mitochondrial EV-mediated transfer upregulates CRLS1 in recipient neurons following ischemia, which preserves inner mitochondrial membrane integrity and stabilizes respiratory chain complexes, reduces ROS production, and suppresses pyroptosis.","method":"hUCMSC mitochondrial EV transfer to neurons, CRLS1 protein expression measurement, mitochondrial membrane potential assay, respiratory chain complex assessment, ROS and pyroptosis readouts","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, functional readouts tied to CRLS1 upregulation but mechanistic dissection of CRLS1 specifically (e.g., mutagenesis or direct KD rescue) not clearly described in abstract","pmids":["41795421"],"is_preprint":false}],"current_model":"CRLS1 (cardiolipin synthase 1) is a mitochondrial inner membrane enzyme that catalyzes two consecutive steps in cardiolipin biosynthesis: acylation of lysophosphatidylglycerol to phosphatidylglycerol (LPG acyltransferase activity) and condensation of phosphatidylglycerol with CDP-diacylglycerol to form cardiolipin; loss of CRLS1 depletes cardiolipin, elevates phosphatidylglycerol, disrupts mitochondrial cristae structure, impairs OXPHOS complex stability, and in humans causes autosomal recessive multi-system mitochondrial disease, while in skeletal muscle its age-dependent decline drives mitochondrial dysfunction and impaired myogenesis."},"narrative":{"mechanistic_narrative":"CRLS1 is the cardiolipin synthase that catalyzes the terminal, committed step of mitochondrial cardiolipin biosynthesis, condensing phosphatidylglycerol with CDP-diacylglycerol at the mitochondrial inner membrane; this activity was established for the yeast ortholog CLS1, whose disruption abolished cardiolipin synthase activity, eliminated detectable cardiolipin, and elevated phosphatidylglycerol ~5-fold [PMID:9614098]. The human enzyme is bifunctional, carrying an additional acyl-CoA-dependent lysophosphatidylglycerol acyltransferase activity that remodels phosphatidylglycerol with defined acyl-chain selectivity (C18:1 > C18:2 > C18:0 > C16:0), coupling PG remodeling to cardiolipin production [PMID:20025994]. Loss of CRLS1 function depletes cardiolipin, shifts cardiolipin acyl-chain composition, and accumulates the PG substrate, in turn disrupting mitochondrial cristae structure, OXPHOS complex stability and mitochondrial biogenesis, and triggering ER and mitochondrial stress responses [PMID:35147173, PMID:38556544]. Biallelic loss-of-function variants in CRLS1 cause a human cardiolipin deficiency disorder, demonstrated in patient-derived fibroblasts with reduced cardiolipin and impaired mitochondrial morphology [PMID:35147173]. Functionally, CRLS1-dependent mitochondrial quality control is required for skeletal muscle myogenesis and regeneration [PMID:38556544], and CRLS1 activity is positioned within mitochondrial phospholipid homeostasis such that cardiolipin synthesis contributes to lipid-overload-driven apoptosis when phospholipid efflux is blocked [PMID:bio_10.1101_2025.09.30.679455].","teleology":[{"year":1998,"claim":"Established the core catalytic identity of the gene: that CLS1/CRLS1 performs the final condensation step of cardiolipin synthesis at the mitochondrial inner membrane, resolving where cardiolipin is made and by what reaction.","evidence":"Gene disruption and heterologous overexpression in yeast and baculovirus-infected insect cells with enzymatic activity and lipid analysis","pmids":["9614098"],"confidence":"High","gaps":["Characterized in yeast ortholog; human enzyme kinetics and structure not addressed","No structural model of the active site or membrane topology"]},{"year":2009,"claim":"Revealed that the human enzyme is bifunctional, adding an acyl-CoA-dependent LPG acyltransferase activity, which connected PG remodeling to cardiolipin production rather than treating CRLS1 as a single-reaction synthase.","evidence":"Purified recombinant hCLS1 in vitro acyltransferase assays with acyl selectivity profiling and overexpression lipid profiling in COS-7 cells","pmids":["20025994"],"confidence":"High","gaps":["Physiological contribution of the LPG acyltransferase activity in vivo not established","No structural basis for dual catalysis"]},{"year":2022,"claim":"Tied CRLS1 directly to human disease, showing biallelic loss-of-function causes cardiolipin deficiency with accumulated PG substrate and mitochondrial dysfunction, converting the enzymatic role into a defined Mendelian disorder.","evidence":"Patient-derived fibroblast lipidomics and proteomics, mouse Crls1 knockout cell lines, and mitochondrial morphology imaging","pmids":["35147173"],"confidence":"High","gaps":["Tissue-specific disease mechanisms not dissected","Link between ER/mitochondrial stress response and clinical phenotype unresolved"]},{"year":2024,"claim":"Demonstrated a physiological requirement for CRLS1 in skeletal muscle, showing its activity maintains mitochondrial quality and is needed for myogenic regeneration in vivo.","evidence":"shRNA knockdown and AAV9-mediated knockdown/overexpression in mice, cristae electron microscopy, OXPHOS complex assays, and cardiotoxin-injury regeneration model","pmids":["38556544"],"confidence":"High","gaps":["Mechanism linking cardiolipin to satellite-cell/myoblast function not resolved","Age-dependent decline mechanism not detailed"]},{"year":2025,"claim":"Placed CRLS1 within a broader mitochondrial phospholipid homeostasis network, showing its depletion blocks apoptosis driven by impaired phospholipid efflux, implicating cardiolipin synthesis in pathological lipid-overload death.","evidence":"Genetic epistasis with CRLS1 depletion in BLTP1-deficient cells, apoptosis readout, and lipid profiling (preprint)","pmids":["bio_10.1101_2025.09.30.679455"],"confidence":"Medium","gaps":["Preprint, not peer-reviewed","Direct biochemical link between CRLS1-made cardiolipin and the apoptotic trigger not mechanistically dissected"]},{"year":2026,"claim":"Implicated CRLS1 upregulation as a protective node in ischemic neurons receiving mitochondrial EVs, linking its activity to membrane integrity, respiratory chain stability, and suppression of pyroptosis.","evidence":"hUCMSC mitochondrial EV transfer to neurons with CRLS1 expression, membrane potential, respiratory complex, ROS, and pyroptosis readouts","pmids":["41795421"],"confidence":"Medium","gaps":["Causal role of CRLS1 not isolated by direct knockdown/rescue in this system","Mechanism of CRLS1 upregulation upon EV transfer unknown"]},{"year":null,"claim":"How CRLS1 coordinates its two enzymatic activities, what governs its acyl-chain selectivity in vivo, and how its loss is sensed to drive ER/mitochondrial stress and tissue-specific phenotypes remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of the catalytic mechanism or membrane topology","Regulation of CRLS1 expression/activity across tissues and aging not defined","Mechanistic coupling between cardiolipin loss and downstream stress/apoptosis pathways incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1]},{"term_id":"GO:0016874","term_label":"ligase activity","supporting_discovery_ids":[0]}],"localization":[],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,1,2]}],"complexes":[],"partners":[],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9UJA2","full_name":"Cardiolipin synthase (CMP-forming)","aliases":["Protein GCD10 homolog"],"length_aa":301,"mass_kda":32.6,"function":"Catalyzes the synthesis of cardiolipin (CL) (diphosphatidylglycerol) by specifically transferring a phosphatidyl group from CDP-diacylglycerol to phosphatidylglycerol (PG) (PubMed:16547353, PubMed:16678169, PubMed:16716149, PubMed:35147173). CL is a key phospholipid in mitochondrial membranes and plays important roles in maintaining the functional integrity and dynamics of mitochondria under both optimal and stress conditions (PubMed:35147173)","subcellular_location":"Mitochondrion inner membrane","url":"https://www.uniprot.org/uniprotkb/Q9UJA2/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/CRLS1","classification":"Common Essential","n_dependent_lines":788,"n_total_lines":1208,"dependency_fraction":0.652317880794702},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CRLS1","total_profiled":1310},"omim":[{"mim_id":"620167","title":"COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 57; COXPD57","url":"https://www.omim.org/entry/620167"},{"mim_id":"617042","title":"GASDERMIN D; GSDMD","url":"https://www.omim.org/entry/617042"},{"mim_id":"612360","title":"NADH DEHYDROGENASE (UBIQUINONE) COMPLEX I, ASSEMBLY FACTOR 5; NDUFAF5","url":"https://www.omim.org/entry/612360"},{"mim_id":"609060","title":"COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1","url":"https://www.omim.org/entry/609060"},{"mim_id":"608188","title":"CARDIOLIPIN SYNTHASE 1; CRLS1","url":"https://www.omim.org/entry/608188"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"liver","ntpm":158.4}],"url":"https://www.proteinatlas.org/search/CRLS1"},"hgnc":{"alias_symbol":["dJ967N21.6","CLS1","GCD10"],"prev_symbol":["C20orf155"]},"alphafold":{"accession":"Q9UJA2","domains":[{"cath_id":"1.20.120.1760","chopping":"108-297","consensus_level":"medium","plddt":86.5948,"start":108,"end":297}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UJA2","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UJA2-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UJA2-F1-predicted_aligned_error_v6.png","plddt_mean":69.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CRLS1","jax_strain_url":"https://www.jax.org/strain/search?query=CRLS1"},"sequence":{"accession":"Q9UJA2","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UJA2.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UJA2/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UJA2"}},"corpus_meta":[{"pmid":"9614098","id":"PMC_9614098","title":"Isolation and characterization of the gene (CLS1) encoding cardiolipin synthase in Saccharomyces cerevisiae.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9614098","citation_count":170,"is_preprint":false},{"pmid":"35147173","id":"PMC_35147173","title":"Deleterious variants in CRLS1 lead to cardiolipin deficiency and cause an autosomal recessive multi-system mitochondrial disease.","date":"2022","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35147173","citation_count":36,"is_preprint":false},{"pmid":"23106435","id":"PMC_23106435","title":"Alternative cardiolipin synthase Cls1 compensates for stalled Cls2 function in Staphylococcus aureus under conditions of acute acid stress.","date":"2012","source":"FEMS microbiology letters","url":"https://pubmed.ncbi.nlm.nih.gov/23106435","citation_count":26,"is_preprint":false},{"pmid":"20025994","id":"PMC_20025994","title":"A novel function of the human CLS1 in phosphatidylglycerol synthesis and remodeling.","date":"2009","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/20025994","citation_count":20,"is_preprint":false},{"pmid":"29434989","id":"PMC_29434989","title":"Expression and potential mechanism of metabolism-related genes and CRLS1 in non-small cell lung cancer.","date":"2017","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/29434989","citation_count":16,"is_preprint":false},{"pmid":"34099597","id":"PMC_34099597","title":"LINC01272 Suppressed Cell Multiplication and Induced Apoptosis Via Regulating MiR-7-5p/CRLS1 Axis in Lung Cancer.","date":"2021","source":"Journal of microbiology and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/34099597","citation_count":13,"is_preprint":false},{"pmid":"38556544","id":"PMC_38556544","title":"Age-dependent loss of Crls1 causes myopathy and skeletal muscle regeneration failure.","date":"2024","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38556544","citation_count":8,"is_preprint":false},{"pmid":"38396958","id":"PMC_38396958","title":"Cytokine Signaling in Pediatric Kidney Tumor Cell Lines WT-CLS1, WT-3ab and G-401.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38396958","citation_count":2,"is_preprint":false},{"pmid":"29972127","id":"PMC_29972127","title":"[Effect of LINE1-ORF1p overexpression on the proliferation of nephroblastoma WT_CLS1 cells].","date":"2018","source":"Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/29972127","citation_count":1,"is_preprint":false},{"pmid":"41116087","id":"PMC_41116087","title":"CRLS1 influences liver metastasis in colon cancer by regulating lipid metabolism pathways.","date":"2025","source":"Functional & integrative genomics","url":"https://pubmed.ncbi.nlm.nih.gov/41116087","citation_count":0,"is_preprint":false},{"pmid":"41795421","id":"PMC_41795421","title":"hUCMSC mitochondrial EVs confer neuroprotection after ischemia by Tom1l2-mediated mitochondrial fusion and Crls1-cardiolipin axis reprogramming.","date":"2026","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/41795421","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.09.30.679455","title":"BLTP1-dependent phospholipid efflux prevents mitochondrial lipid overload and apoptosis at FKBP8-tethered ER-mitochondrial contact","date":"2025-09-30","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.30.679455","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8306,"output_tokens":1905,"usd":0.026746,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8849,"output_tokens":2610,"usd":0.054747,"stage2_stop_reason":"end_turn"},"total_usd":0.081493,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"CLS1 (yeast ortholog of CRLS1) encodes cardiolipin synthase, which catalyzes the final step in cardiolipin synthesis from phosphatidylglycerol and CDP-diacylglycerol, localized predominantly to the mitochondrial inner membrane. Disruption of CLS1 abolished cardiolipin synthase activity, eliminated detectable cardiolipin, and elevated phosphatidylglycerol levels ~5-fold.\",\n      \"method\": \"Gene disruption/knockout, overexpression in yeast and baculovirus-infected insect cells with enzymatic activity assays, lipid analysis, and mitochondrial dye staining\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct enzymatic activity assay in multiple expression systems, null mutant with definitive biochemical phenotype, replicated in yeast and insect cells\",\n      \"pmids\": [\"9614098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Human CRLS1 (hCLS1) possesses a second enzymatic activity: an acyl-CoA-dependent lysophosphatidylglycerol (LPG) acyltransferase that remodels PG by acylating LPG to PG, in addition to its cardiolipin synthase activity. Purified recombinant hCLS1 displayed acyl selectivity (C18:1 > C18:2 > C18:0 > C16:0) for both activities. No significant acyltransferase activity was detected toward lysocardiolipin. Overexpression in COS-7 cells increased both PG biosynthesis and cardiolipin levels without affecting other phospholipids.\",\n      \"method\": \"Recombinant protein expression in COS-7 and Sf-9 insect cells, purified protein in vitro acyltransferase assays, lipid mass spectrometry/radiolabeling, overexpression with lipid profiling\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro enzymatic assay with purified protein, multiple expression systems, acyl selectivity profiling, and cell overexpression functional validation in a single study\",\n      \"pmids\": [\"20025994\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Biallelic loss-of-function variants in human CRLS1 cause cardiolipin deficiency: patient-derived fibroblasts showed reduced cardiolipin levels, altered acyl-chain composition, and significantly elevated phosphatidylglycerol (the CRLS1 substrate), alongside impaired mitochondrial morphology and biogenesis. Mouse Crls1 knockout cell lines revealed endoplasmic reticular and mitochondrial stress responses upon cardiolipin insufficiency.\",\n      \"method\": \"Patient-derived fibroblast lipid profiling (lipidomics), proteomic profiling, mouse Crls1 knockout cell lines, mitochondrial morphology assays (microscopy)\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (lipidomics, proteomics, KO cell lines, morphology imaging) across patient and mouse model systems in a single study\",\n      \"pmids\": [\"35147173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Crls1 knockdown in myoblasts reduced mitochondrial mass, oxidative phosphorylation complex IV expression, and disrupted mitochondrial cristae structure. In vivo, AAV9-shCrls1-mediated Crls1 knockdown impaired muscle regeneration after cardiotoxin injury in mice, whereas AAV9-mCrls1 overexpression improved regeneration, establishing that Crls1 is required for maintaining mitochondrial quality in skeletal muscle myogenesis.\",\n      \"method\": \"shRNA knockdown and AAV9-mediated overexpression/knockdown in mouse model, mitochondrial activity assays, electron microscopy of cristae, in vivo muscle regeneration model\",\n      \"journal\": \"Experimental & molecular medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo loss- and gain-of-function with defined phenotypic readouts (mitochondrial morphology, OXPHOS complex expression, muscle regeneration) in a single study with multiple orthogonal methods\",\n      \"pmids\": [\"38556544\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CRLS1 functions downstream in the cardiolipin synthesis pathway at mitochondria; depletion of CRLS1 (along with PTPMT1 or PRELID1) prevents apoptosis caused by BLTP1 deficiency, indicating that CRLS1-mediated cardiolipin synthesis contributes to pathological lipid overload-driven apoptosis when mitochondrial phospholipid efflux is blocked.\",\n      \"method\": \"Genetic epistasis: CRLS1 depletion in BLTP1-deficient cells with apoptosis readout; lipid profiling showing PG and CL accumulation\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — genetic epistasis with defined apoptosis readout, single preprint lab study, pathway placement supported by lipid accumulation data but not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.09.30.679455\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Mitochondrial EV-mediated transfer upregulates CRLS1 in recipient neurons following ischemia, which preserves inner mitochondrial membrane integrity and stabilizes respiratory chain complexes, reduces ROS production, and suppresses pyroptosis.\",\n      \"method\": \"hUCMSC mitochondrial EV transfer to neurons, CRLS1 protein expression measurement, mitochondrial membrane potential assay, respiratory chain complex assessment, ROS and pyroptosis readouts\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, functional readouts tied to CRLS1 upregulation but mechanistic dissection of CRLS1 specifically (e.g., mutagenesis or direct KD rescue) not clearly described in abstract\",\n      \"pmids\": [\"41795421\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CRLS1 (cardiolipin synthase 1) is a mitochondrial inner membrane enzyme that catalyzes two consecutive steps in cardiolipin biosynthesis: acylation of lysophosphatidylglycerol to phosphatidylglycerol (LPG acyltransferase activity) and condensation of phosphatidylglycerol with CDP-diacylglycerol to form cardiolipin; loss of CRLS1 depletes cardiolipin, elevates phosphatidylglycerol, disrupts mitochondrial cristae structure, impairs OXPHOS complex stability, and in humans causes autosomal recessive multi-system mitochondrial disease, while in skeletal muscle its age-dependent decline drives mitochondrial dysfunction and impaired myogenesis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CRLS1 is the cardiolipin synthase that catalyzes the terminal, committed step of mitochondrial cardiolipin biosynthesis, condensing phosphatidylglycerol with CDP-diacylglycerol at the mitochondrial inner membrane; this activity was established for the yeast ortholog CLS1, whose disruption abolished cardiolipin synthase activity, eliminated detectable cardiolipin, and elevated phosphatidylglycerol ~5-fold [#0]. The human enzyme is bifunctional, carrying an additional acyl-CoA-dependent lysophosphatidylglycerol acyltransferase activity that remodels phosphatidylglycerol with defined acyl-chain selectivity (C18:1 > C18:2 > C18:0 > C16:0), coupling PG remodeling to cardiolipin production [#1]. Loss of CRLS1 function depletes cardiolipin, shifts cardiolipin acyl-chain composition, and accumulates the PG substrate, in turn disrupting mitochondrial cristae structure, OXPHOS complex stability and mitochondrial biogenesis, and triggering ER and mitochondrial stress responses [#2, #3]. Biallelic loss-of-function variants in CRLS1 cause a human cardiolipin deficiency disorder, demonstrated in patient-derived fibroblasts with reduced cardiolipin and impaired mitochondrial morphology [#2]. Functionally, CRLS1-dependent mitochondrial quality control is required for skeletal muscle myogenesis and regeneration [#3], and CRLS1 activity is positioned within mitochondrial phospholipid homeostasis such that cardiolipin synthesis contributes to lipid-overload-driven apoptosis when phospholipid efflux is blocked [#4].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established the core catalytic identity of the gene: that CLS1/CRLS1 performs the final condensation step of cardiolipin synthesis at the mitochondrial inner membrane, resolving where cardiolipin is made and by what reaction.\",\n      \"evidence\": \"Gene disruption and heterologous overexpression in yeast and baculovirus-infected insect cells with enzymatic activity and lipid analysis\",\n      \"pmids\": [\"9614098\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Characterized in yeast ortholog; human enzyme kinetics and structure not addressed\", \"No structural model of the active site or membrane topology\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Revealed that the human enzyme is bifunctional, adding an acyl-CoA-dependent LPG acyltransferase activity, which connected PG remodeling to cardiolipin production rather than treating CRLS1 as a single-reaction synthase.\",\n      \"evidence\": \"Purified recombinant hCLS1 in vitro acyltransferase assays with acyl selectivity profiling and overexpression lipid profiling in COS-7 cells\",\n      \"pmids\": [\"20025994\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological contribution of the LPG acyltransferase activity in vivo not established\", \"No structural basis for dual catalysis\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Tied CRLS1 directly to human disease, showing biallelic loss-of-function causes cardiolipin deficiency with accumulated PG substrate and mitochondrial dysfunction, converting the enzymatic role into a defined Mendelian disorder.\",\n      \"evidence\": \"Patient-derived fibroblast lipidomics and proteomics, mouse Crls1 knockout cell lines, and mitochondrial morphology imaging\",\n      \"pmids\": [\"35147173\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific disease mechanisms not dissected\", \"Link between ER/mitochondrial stress response and clinical phenotype unresolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstrated a physiological requirement for CRLS1 in skeletal muscle, showing its activity maintains mitochondrial quality and is needed for myogenic regeneration in vivo.\",\n      \"evidence\": \"shRNA knockdown and AAV9-mediated knockdown/overexpression in mice, cristae electron microscopy, OXPHOS complex assays, and cardiotoxin-injury regeneration model\",\n      \"pmids\": [\"38556544\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking cardiolipin to satellite-cell/myoblast function not resolved\", \"Age-dependent decline mechanism not detailed\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Placed CRLS1 within a broader mitochondrial phospholipid homeostasis network, showing its depletion blocks apoptosis driven by impaired phospholipid efflux, implicating cardiolipin synthesis in pathological lipid-overload death.\",\n      \"evidence\": \"Genetic epistasis with CRLS1 depletion in BLTP1-deficient cells, apoptosis readout, and lipid profiling (preprint)\",\n      \"pmids\": [\"bio_10.1101_2025.09.30.679455\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint, not peer-reviewed\", \"Direct biochemical link between CRLS1-made cardiolipin and the apoptotic trigger not mechanistically dissected\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Implicated CRLS1 upregulation as a protective node in ischemic neurons receiving mitochondrial EVs, linking its activity to membrane integrity, respiratory chain stability, and suppression of pyroptosis.\",\n      \"evidence\": \"hUCMSC mitochondrial EV transfer to neurons with CRLS1 expression, membrane potential, respiratory complex, ROS, and pyroptosis readouts\",\n      \"pmids\": [\"41795421\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal role of CRLS1 not isolated by direct knockdown/rescue in this system\", \"Mechanism of CRLS1 upregulation upon EV transfer unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How CRLS1 coordinates its two enzymatic activities, what governs its acyl-chain selectivity in vivo, and how its loss is sensed to drive ER/mitochondrial stress and tissue-specific phenotypes remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of the catalytic mechanism or membrane topology\", \"Regulation of CRLS1 expression/activity across tissues and aging not defined\", \"Mechanistic coupling between cardiolipin loss and downstream stress/apoptosis pathways incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005743\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 1, 2]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}